Brooks O'Neil

Stock Analyst at Lake Street

(1.29)
# 3,389
Out of 4,734 analysts
30
Total ratings
40%
Success rate
-12.05%
Average return

Stocks Rated by Brooks O'Neil

ModivCare
Jan 13, 2025
Maintains: Buy
Price Target: $30$10
Current: $5.94
Upside: +68.35%
AVITA Medical
Jan 8, 2025
Maintains: Buy
Price Target: $20$14
Current: $8.73
Upside: +60.37%
LifeVantage
Dec 19, 2024
Initiates: Buy
Price Target: $26
Current: $24.93
Upside: +4.29%
LifeMD
Dec 10, 2024
Initiates: Buy
Price Target: $12
Current: $5.17
Upside: +132.11%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45$55
Current: $36.10
Upside: +52.35%
Alphatec Holdings
Sep 3, 2024
Maintains: Buy
Price Target: $32$18
Current: $11.61
Upside: +55.04%
Organogenesis Holdings
Jun 28, 2024
Initiates: Buy
Price Target: $5
Current: $3.53
Upside: +41.64%
Surmodics
May 29, 2024
Downgrades: Hold
Price Target: $43
Current: $37.50
Upside: +14.67%
Tandem Diabetes Care
May 22, 2024
Maintains: Buy
Price Target: $60$75
Current: $35.30
Upside: +112.46%
P3 Health Partners
Mar 14, 2024
Maintains: Buy
Price Target: $9$4.5
Current: $0.20
Upside: +2,173.88%
Initiates: Buy
Price Target: $12
Current: $9.14
Upside: +31.29%
Maintains: Buy
Price Target: $65$75
Current: $99.65
Upside: -24.74%
Maintains: Buy
Price Target: $20$26
Current: $33.90
Upside: -23.30%
Assumes: Buy
Price Target: $45
Current: $3.88
Upside: +1,059.79%
Initiates: Buy
Price Target: $11
Current: $1.19
Upside: +824.37%